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TGF-b signaling is mediated through two types of serine/threonin kinase-containing receptors, type I (TGF-bRI) and type
II (TGF-bRII), which form a heteromeric complex. In this signaling complex, ligand binding TGF-bRII phosphorylates and
thereby activates the TGF-bRI to signal downstream pathways. To determine the role of TGF-bRII in embryogenesis, we
have generated a TGF-bRII gene (Tgfbr2) knockout mouse line. The heterozygous Tgfbr2 knockout mice are developmen-
tally normal. The homozygous Tgfbr2 mutation causes defects in the yolk sac hematopoiesis and vasculogenesis, resulting
in an embryonic lethality around 10.5 days of gestation. This phenotype is indistinguishable from the previously reported
embryonic lethality by the homozygous TGF-b1 gene (Tgfb1) null mutation. In addition, we have generated chimeric mice
using a Tgfbr2 (0/0) embryonic stem cell line. Some chimeric mice showed several types of congenital anomalies, sug-
gesting that TGF-bRII is important for normal development in a variety of organs. q 1996 Academic Press, Inc.
INTRODUCTION homozygous embryos die at 10 days of gestation due to
hematopoietic and vasculogenetic defects in the yolk sac
(Dickson et al., 1995). This phenomenon suggests that there
Transforming growth factor-b (TGF-b) signaling is medi- is a pathway which rescues the defects in the embryos by
ated by two types of serine/threonin kinase-containing re- another compensation factor. Recently, Tgfb3 was knocked
ceptors, the type I (TGF-bRI) and type II (TGF-bRII) recep- out (Proetzel et al., 1995; Kaartinen et al., 1995). The homo-
tors, which form a heteromeric complex, in which TGF- zygous mutant mice were born, although they showed ab-
bRII phosphorylates TGF-bRI (for a review see Derynck, normal lung development and cleft palate.
1994). During the midgestation, TGF-bRII has a de®ned ex- To investigate the role of signaling through TGF-bRII in
pression pattern which largely correlates with that of TGF- embryogenesis, we have constructed Tgfbr2 knockout mice.
b1 (Lawler et al., 1994). Based on their expression in em- Here we present the results indicating that TGF-bRII is
bryogenesis, it is assumed that TGF-bRII have important essential for hematopoiesis and vasculogenesis in the yolk
functions in mammalian development. TGF-bRII has a high sac and for development of several organs.
af®nity for TGF-b1 and TGF-b3, but not for TGF-b2 (Lawler
et al., 1994), whereas the high-af®nity receptor for TGF-b2
is composed of a heterooligomer of TGF-bRI and TGF-bRII MATERIALS AND METHODS
(Rodoriguez et al., 1995).
Among these ligands of TGF-bRII, the genes encoding
Construction of Tgfbr2 targeting vector. To isolate the murineTGF-b1 (Tgfb1) and TGF-b3 (Tgfb3) were inactivated by the
TGF-bRII gene (Tgfbr2), the cDNA fragment of the entire extracel-
knockout technology, while the gene for TGF-b2 (Tgfb2) lular domain (Lawler et al., 1994) was used to screen a mouse
has not been knocked out. Inactivation of mouse Tgfb1 re- 129/Sv genomic library (Stratagene). One of the clones contained
sults in a wasting syndrome with diffuse in¯ammatory in- a single exon, which encoded codons from 151 to 418 including the
®ltrates in the homozygous newborn animals (Shull et al., transmembrane domain. Based on the sequence of several genomic
clones, this exon was numbered as exon 4, with the exon containing1992; Kulkarni et al., 1993). However, about a half of Tgfb1
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FIG. 1. Disruption of the TGF-bRII gene (Tgfbr2) in mouse embryonic stem (ES) cells. (a) Schematic representation of the targeting
strategy by homologous recombination. The ®rst and second lines illustrate the hygromycin (Hygro)- and the neomycin (Neo)-targeting
vectors, respectively, whereas the third line shows the wild-type allele. The targeted Tgfbr2 alleles are shown in lines 4 and 5. Solid boxes
indicate the tentative exons 1 to 4 of the Tgfbr2 gene; gray boxes in exon 4 indicate the transmembrane domain; labeled open boxes
indicate the PGKNeo, PGKHygro, and PGKDT-A selection cassettes. The position of the translation initiation codon is shown by an
asterisk. The probe used for Southern analysis is shown by a hatched box. Arrowheads bF2, bF, bR, and PGKr indicate the PCR primers.
Relevant restriction sites are abbreviated as follows: H, HincII; K, KpnI; Pm, PmaCI; Ps, PstI; X, XhoI. (b) Southern analysis of ES cell
DNAs after HincII digestion, using a probe shown in (a). The 1.7-kb fragment corresponding to the wild-type allele is converted to 4.2-
and 2.3-kb fragments upon disruption of the gene by insertion of the Neo and Hygro genes, respectively. DNA derived from the parental
ES cells (///), single-targeted ES cells (//0), and double-targeted ES cells (0/0) are shown. In one of the lanes of (0/0) ES cells, a faint
band for the wild-type allele is observed, which derived from mouse embryonic ®broblasts used as a feeder layer. (c) Genotyping of
intercross offsprings by allele-speci®c PCR using the primer sets shown in (a). Results of wild-type allele-speci®c PCR with primers bF
and bR (WT; top) and Neo targeted allele-speci®c PCR with primers bF and PGKr (Neo; bottom) are shown. The band immediately below
the 550-bp Neo band is a nonspeci®c PCR product. (d) RT-PCR analysis of ES cell RNA using the wild-type and mutant mRNA-speci®c
primer sets. Results of the wild-type mRNA-speci®c RT-PCR with primers bF2 and bR (top) and the targeted mRNA-speci®c RT-PCR
with primers bF2 and PGKr (bottom) are shown.
the ATG translation initiation codon de®ned as exon 1, tentatively theria toxin a-subunit gene (DT-A) (Yagi et al., 1990) driven by the
PGK promoter was ligated upstream of the short homology arm(Fig. 1a). Targeting vectors were constructed by inserting the PGK-
Neo and PGK-Hygro cassettes into the PstI site at codon 230 and for a negative selection (Oshima et al., 1995). The targeted genes
were expected to encode proteins truncated at positions upstreamPmaCI site at codon 306, respectively (Fig. 1a). The bacterial diph-
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of the cytoplasmic kinase domain due to inframe stop codons intro- and then rinsed with distilled water. The sections were stained
with hematoxylin and eosin.duced by the PGK promoter sequence.
Gene targeting of Tgfbr2 in embryonic stem (ES) cells. ES cell
line D3a2 was cultured as described (Shull et al., 1992; Oshima et
al., 1995). About 2 1 107 ES cells were electroporated with the RESULTS AND DISCUSSIONlinearized Neo targeting vector at 0.25 kV and 500 mF. Of 140 clones
that were resistant to G418 (250 mg/ml, Sigma), 6 ES clones were
identi®ed as correctly targeted at one of the Tgfbr2 alleles by South- To inactivate the TGF-bRII gene (Tgfbr2), a truncation
ern analysis using a probe shown in Fig. 1a. To obtain Tgfbr2 (0/ mutation was introduced at an upstream position of the
0) ES cell clones, the Tgfbr2 (//0) ES cells were electroporated cytoplasmic serine/threonin kinase domain in mouse ES
with the Hygro targeting vector and selected with Hygromycin B cells (Fig. 1a). This design should shut off the ligand-medi-
(300 mg/ml, Sigma). By Southern analysis, 2 of 96 clones were iden- ated signal transduction although the ligand binding may
ti®ed as correctly targeted at both alleles. take place normally. Single- (Tgfbr2 //0) and double-tar-
Generation of chimeric mice. Ten to 12 Tgfbr2 (//0) ES cells
geted (Tgfbr2 0/0) ES clones were obtained by homologouswere injected into the blastocoel of each C57BL/6J embryo, and the
recombination using the Neo and Neo/Hygro targeting vec-embryos were transferred to pseudopregnant MCH females (CLEA
tors, respectively. The expected homologous recombinationJapan, Tokyo). Chimeric males showing greater than 80% contribu-
events were con®rmed by Southern hybridization of thetion to the coat color by the ES cells were mated with C57BL/6J
genomic DNA (Fig. 1b). Further analysis by RT-PCR demon-females. The agouti offsprings were genotyped for the Tgfbr2 gene
by PCR of the tail DNA. The Tgfbr2 (0/0) chimeric mice were strated that the wild-type mRNA was not generated from
generated by the same method except reducing the number of the either the Neo- or Hygro-targeted allele (Fig. 1d).
injected ES cells to 3±10. Germline-transmitted knockout mice were generated
Genotyping of ES cells and mouse tissues. Genomic DNA was from Tgfbr2 (//0) ES cell lines. The F1 Tgfbr2 (//0) mice
prepared from ES cells, yolk sacs, and tails after treatment with were developmentally normal and fertile. When the Tgfbr2
proteinase K. Allele-speci®c PCR were performed using the follow- (//0) mice were intercrossed, only the wild-type and Tgfbr2
ing primer sets: bF (5*-TGATTATGGACTTGCTTCCCGGTA-3* (//0) pups were born, suggesting that the Tgfbr2 (0/0) em-
from the intron 3 sequence) with bR (5*-CGAAGTCACACAGGC-
bryos were lethal. To determine the lethal stage of Tgfbr2AACAGGTCA-3* from the coding sequence of exon 4 correspond-
(0/0), embryos from heterozygous crosses were examineding to codons 391±398) to detect the wild allele and PGKr (5*-
from 8.5 to 13.5 days postcoitum (dpc) and genotyped.CTAAAGCGCATGCTCCAGACT-3* from the PGK promoter se-
On 8.5 dpc, the Tgfbr2 (0/0) embryos were not distinguish-quence) with bF to detect the targeted allele.
able from other littermates under a dissecting microscope.RT-PCR. Total RNA was isolated from several ES cell lines
using ISOGEN (Nippon Gene, Japan). Reverse transcription reac- By 9.5 dpc, however, the Tgfbr2 (0/0) yolk sac showed a
tion was performed using 10 mg of total RNA and 100 pmole of severe anemia (Fig. 2a) and the embryo proper had a mild
synthetic primer bR or PGKr with Superscript RT (BRL). Standard growth retardation, although they appeared normal morpho-
PCR were then performed with forward primer bF2 (5*-CTTTCT- logically (data not shown). On 10.5 and 11.5 dpc, the Tgfbr2
TCATGTGTGCCTGTAACA-3*) from the coding sequence of exon (0/0) embryos showed a marked growth retardation com-
3 corresponding to codons 132±138. The expected lengths of RT- pared with their littermates (Fig. 2b). This phenotype may
PCR products are 800, 540, and 310 bp for mRNAs from the wild-
be a secondary effect of the yolk sac insuf®ciency. On 13.5type, Neo, and Hygro alleles, respectively (Fig. 1d).
dpc, no live Tgfbr2 (0/0) embryos were observed, althoughHistological analysis. Embryos and tissue specimens were
there were resorbed deciduas in a reasonable number.®xed overnight in 4% paraformaldehyde/PBS, dehydrated in in-
Histological analysis of the Tgfbr2 (0/0) yolk sacs at 9.5creasing concentrations of ethanol (70, 80, 90, and 100%), and em-
dpc revealed defects in hematopoiesis and vascular develop-bedded in paraf®n wax. Paraf®n sections of 4 mm were treated with
xylene, rehydrated in graded series of ethanol (100, 90, and 70%), ment. In the wild-type yolk sacs, two endothelial layers
FIG. 2. Morphological and histological analyses of the embryos obtained from the Tgfbr2 (//0) intercross (a±d) and the chimeras
constructed from the Tgfbr2 (0/0) ES cell line (e±h). (a) A Tgfbr2 (0/0) conceptus at 9.5 dpc with yolk sac anemia (right), compared with
that of a wild-type littermate (left). Scale bar, 1 mm. (b) A Tgfbr2 (0/0) embryo at 10.5 dpc (right) showing a growth retardation and a
reduced size, compared with a wild-type littermate (left). Scale bar, 500 mm. (c) Histological section of a wild-type yolk sac at 9.5 dpc.
Endothelial cells forming vascular vessels included blood cells. (d) A Tgfbr2 (0/0) yolk sac at 9.5 dpc. Compared with (c), endothelial
adhesion is disrupted, resulting in a separation of the two endothelial layers. There are few blood cells in the space between the two
endothelial layers of the Tgfbr2 (0/0) yolk sac. Scale bars, 25 mm each. (e) A cystic swelling containing a serous ¯uid in the left kidney
of a chimera derived from the Tgfbr2 (0/0) ES cell line. Scale bar, 2 mm. (f) An internal hydrocephalus with internal hemorrhage of a
chimeric mouse (right) and a normal brain control (left). Transverse section. Scale bar, 2 mm. (g) A head of a 5-day-old chimeric pup with
a swelling caused by an internal hydrocephalus (right) compared with a normal pup (left). Scale bar, 10 mm. (h) A neonatal pup, constructed
by an injection of the Tgfbr2 (0/0) ES cells, showing agnathia with anophthalmia and synotia (right) compared with a normal neonate
(left). Scale bar, 5 mm.
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were attached to the mesothelial and endodermal cell lay- (0/0) cells, because we have never observed such a pheno-
type in numerous experiments of chimeric mouse produc-ers, forming capillary-like vessels containing blood cells in-
side (Fig. 2c). In contrast, these cell layers were partially tion. Thus, these chimeric mice can be good models for
human rare malformations.detached in the Tgfbr2 (0/0) yolk sac, and the contacts of
the two endothelial layers were not complete (Fig. 2d). This In these chimeras, we could not determine which particu-
lar cell lineages the Tgfbr2 (0/0) ES cells contributed to,abnormal structure resulted in a distended capillary vessel
formation. Furthermore, there were considerably fewer because of their very low contribution. Recently, the TGF-
b3 gene (Tgfb3) that encodes another high-af®nity ligandblood cells in the space between the endothelial layers of
the Tgfbr2 (0/0) yolk sacs than in the wild-type yolk sacs. for TGF-bRII was knocked out (Proetzel et al., 1995; Kaarti-
nen et al., 1995). Homozygous Tgfb3 mutant mice wereThese ®ndings indicate that the signaling through TGF-
bRII is necessary for hematopoiesis and vasculogenesis in born, although they showed abnormal lung development
and cleft palate. Accordingly, it is unlikely that the malfor-the yolk sac.
These histological features of the Tgfbr2 (0/0) yolk sac mations of Tgfbr2 (0/0) chimeras were caused by a defect in
the signaling by TGF-b1 or -b3. Together with the knockoutare almost identical with those in the TGF-b1 gene (Tgfb1)
knockout homozygous embryos. About half of them die mice in the TGF-b1, -b2, and -b3 genes, the Tgfbr2 knock-
out mice should provide us an experimental tool that helpsaround 10.5 dpc due to defects in hematopoiesis and vascu-
logenesis in the yolk sac (Dickson et al., 1995). The expres- understand the role of the TGF-b system in normal and
abnormal development.sion pattern of TGF-b1 and TGF-bRII showed a remarkable
similarity in embryogenesis (Lawler et al., 1994). Accord-
ingly, this phenotype of the Tgfbr2 homozygous embryos
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